Literature DB >> 16532030

Histone deacetylase 3 localizes to the plasma membrane and is a substrate of Src.

M S Longworth1, L A Laimins.   

Abstract

Histone deacetylases (HDACs) negatively regulate gene expression by removing acetyl groups from lysine residues present in histones and other proteins. Histone deacetylase 3 is unique among the Class I family of HDACs, as it is able to shuttle between the nucleus and the cytoplasm, whereas the other family members remain in the nucleus. Histone deacetylase 3 often forms complexes with corepressor proteins that do not associate with the other Class I HDACs, and its phosphorylation correlates with increased enzymatic activity. Here we show that HDAC3 also localizes to the plasma membrane in multiple cell types. Furthermore, c-Src is shown to form a complex with HDAC3 at the plasma membrane and to use HDAC3 as a substrate for phosphorylation. Our results describe a novel localization and binding partner for the HDAC3 protein, as well as implicate c-Src in HDAC3 regulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16532030     DOI: 10.1038/sj.onc.1209473

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  58 in total

1.  Strong expression of HDAC3 correlates with a poor prognosis in patients with adenocarcinoma of the lung.

Authors:  Yoshihiro Minamiya; Takashi Ono; Hajime Saito; Naoko Takahashi; Manabu Ito; Satoru Motoyama; Junichi Ogawa
Journal:  Tumour Biol       Date:  2010-06-19

Review 2.  Metabolism, cytoskeleton and cellular signalling in the grip of protein Nepsilon - and O-acetylation.

Authors:  Xiang-Jiao Yang; Serge Grégoire
Journal:  EMBO Rep       Date:  2007-06       Impact factor: 8.807

Review 3.  Emerging roles for histone deacetylases in pulmonary hypertension and right ventricular remodeling (2013 Grover Conference series).

Authors:  Maria A Cavasin; Kurt R Stenmark; Timothy A McKinsey
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

Review 4.  Anticancer potential of the histone deacetylase inhibitor-like effects of flavones, a subclass of polyphenolic compounds: a review.

Authors:  Prabhat Singh; Raghuvir Singh Tomar; Srikanta Kumar Rath
Journal:  Mol Biol Rep       Date:  2015-06-02       Impact factor: 2.316

5.  Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.

Authors:  Muralidharan Anbalagan; Mei Sheng; Brian Fleischer; Yifang Zhang; Yuanjun Gao; Van Hoang; Margarite Matossian; Hope E Burks; Matthew E Burow; Bridgette M Collins-Burow; David Hangauer; Brian G Rowan
Journal:  Mol Cancer Res       Date:  2017-07-27       Impact factor: 5.852

6.  Histone Deacetylase 3 (HDAC3)-dependent Reversible Lysine Acetylation of Cardiac Myosin Heavy Chain Isoforms Modulates Their Enzymatic and Motor Activity.

Authors:  Sadhana A Samant; Vinodkumar B Pillai; Nagalingam R Sundaresan; Sanjeev G Shroff; Mahesh P Gupta
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

7.  Histone deacetylase inhibitors as cancer therapeutics.

Authors:  Gary A Clawson
Journal:  Ann Transl Med       Date:  2016-08

8.  Histone deacetylase inhibitors prevent pulmonary endothelial hyperpermeability and acute lung injury by regulating heat shock protein 90 function.

Authors:  Atul D Joshi; Nektarios Barabutis; Charalampos Birmpas; Christiana Dimitropoulou; Gagan Thangjam; Mary Cherian-Shaw; John Dennison; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-23       Impact factor: 5.464

9.  Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis.

Authors:  Heather R Pelzel; Cassandra L Schlamp; Robert W Nickells
Journal:  BMC Neurosci       Date:  2010-05-26       Impact factor: 3.288

Review 10.  The tale of protein lysine acetylation in the cytoplasm.

Authors:  Karin Sadoul; Jin Wang; Boubou Diagouraga; Saadi Khochbin
Journal:  J Biomed Biotechnol       Date:  2010-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.